Skip to content

Opening book details…

About this Medicine article

Managing the Risk of CYP3A Induction in Drug Development: A Strategic Approach by Jones, B. C.; Rollison, H.; Johansson, S.; Kanebratt, K. P.; Lambert, C.; Vishwanathan, K.; Andersson, T. B. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Jones, B. C.; Rollison, H.; Johansson, S.; Kanebratt, K. P.; Lambert, C.; Vishwanathan, K.; Andersson, T. B.
Publisher
American Society for Pharmacology and Experimental Therapeutics; American Society for Pharmacology & Experimental Therapeutics; American Society for Pharmacology & Experimental Therapeutics (ASPET) (ISSN 0090-9556)
Published
2016
Field
Medicine (Life Sciences)

More by Jones, B. C.; Rollison, H.; Johansson, S.; Kanebratt, K. P.; Lambert, C.; Vishwanathan, K.; Andersson, T. B.

Browse all works by Jones, B. C.; Rollison, H.; Johansson, S.; Kanebratt, K. P.; Lambert, C.; Vishwanathan, K.; Andersson, T. B.